| Code | Description | Claims | Beneficiaries | Total Paid |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,851 |
3,806 |
$151K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,795 |
1,606 |
$70K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
881 |
791 |
$39K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,226 |
851 |
$15K |
| S8301 |
Infection control supplies, not otherwise specified |
1,254 |
931 |
$15K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
987 |
473 |
$12K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
482 |
443 |
$6K |
| 99309 |
Subsequent nursing facility care, per day, low to moderate complexity |
621 |
594 |
$6K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
42 |
38 |
$2K |
| 99408 |
|
88 |
80 |
$1K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
98 |
41 |
$1K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
13 |
13 |
$900.90 |
| 99396 |
Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years |
12 |
12 |
$840.07 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
12 |
12 |
$795.32 |
| 93000 |
|
76 |
72 |
$791.37 |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
251 |
237 |
$692.55 |
| 99000 |
|
73 |
67 |
$443.36 |
| 99407 |
|
33 |
28 |
$394.94 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
14 |
14 |
$347.79 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
65 |
54 |
$345.43 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
162 |
136 |
$274.36 |
| 0012A |
|
27 |
27 |
$251.25 |
| 0031A |
|
17 |
16 |
$227.12 |
| 99473 |
|
52 |
49 |
$213.79 |
| 80305 |
|
33 |
30 |
$201.02 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
33 |
29 |
$165.42 |
| 0011A |
|
26 |
24 |
$135.52 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
87 |
72 |
$133.41 |
| 94760 |
|
297 |
225 |
$119.66 |
| 81002 |
|
44 |
36 |
$110.65 |
| 90461 |
|
15 |
12 |
$107.27 |
| 97802 |
|
97 |
95 |
$90.88 |
| 87807 |
|
12 |
12 |
$79.20 |
| 99072 |
|
43 |
29 |
$25.00 |
| 91303 |
|
17 |
16 |
$0.20 |
| 91301 |
|
59 |
55 |
$0.20 |
| 99070 |
|
927 |
720 |
$0.00 |
| 3008F |
|
1,024 |
777 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
196 |
181 |
$0.00 |
| G0439 |
Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit |
12 |
12 |
$0.00 |
| 1036F |
|
29 |
27 |
$0.00 |
| 3074F |
|
14 |
13 |
$0.00 |
| 99318 |
|
15 |
15 |
$0.00 |
| 3725F |
|
659 |
616 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
53 |
47 |
$0.00 |
| 99307 |
|
31 |
30 |
$0.00 |
| G9898 |
Patients age 66 or older in institutional special needs plans (snp) or residing in long-term care with pos code 32, 33, 34, 54, or 56 for more than 90 consecutive days during the measurement period |
13 |
13 |
$0.00 |
| 1160F |
|
576 |
407 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
16 |
13 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
266 |
217 |
$0.00 |
| 1159F |
|
650 |
524 |
$0.00 |
| 99401 |
|
13 |
12 |
$0.00 |
| 3078F |
|
15 |
13 |
$0.00 |